US Patent 11851659 Compositions and methods for immunooncology

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118516590

Patent Inventor Names

Hyungwook Lim0

Jennifer Brogdon0

Sarah Hesse0

Ming-Wei Chen0

Yi Yang0

Morag Stewart0

Date of Patent

December 26, 2023

Patent Application Number

164983610

Date Filed

March 21, 2018

Patent Citations

‌

US Patent 7754482 Artificial antigen presenting cells and uses therefor

‌

US Patent 9422351 Isolated B7-H4 specific compositions and methods of use thereof

‌

US Patent 9446105 Chimeric antigen receptor specific for folate receptor β

‌

US Patent 9464140 Compositions and methods for treatment of cancer

‌

US Patent 9481728 Compositions and methods for treatment of cancer

‌

US Patent 9499629 Use of chimeric antigen receptor-modified T-cells to treat cancer

‌

US Patent 9518123 Compositions and methods for treatment of cancer

‌

US Patent 9540445 Compositions and methods for treatment of cancer

...

Patent Primary Examiner

CPC Code

...

Patent abstract

The present disclosure is directed to genome editing systems, reagents and methods for immunooncology.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11851659 Compositions and methods for immunooncology

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11851659 Compositions and methods for immunooncology